Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:56 AM
Ignite Modification Date:
2025-12-25 @ 3:56 AM
NCT ID:
NCT01884402
Eligibility Criteria:
Inclusion Criteria:
* Patients with \> 18 years old.
* Patients diagnosed with chronic hepatitis C in the presence of HCV RNA in plasma that meet criteria for initiating antiviral therapy in routine clinical practice conditions.
* Patients Genotype 1 and 4.
* Patients with the results of all the factors evaluable at the time of inclusion.
* Patients who have accepted their participation in the study through informed consent.
Exclusion Criteria:
* Patients previously treated with interferon (IFN) and ribavirin (RBV).
* Patients with genotype 2, 3, 5 and 6.
* Patients with co-infection with hepatitis B.
* Patients with other liver diseases.
* Patients with any contraindications to the drugs used in the treatment of hepatitis C.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT01884402
Study Brief:
Protocol Section:
NCT01884402